Clinical Study

Analysis of Serum and Urinal Copper and Zinc in Chinese Northeast Population with the Prediabetes or Diabetes with and without Complications

Table 3

Associations between serum Cu or urinary Cu level as a continuous variable and laboratory parameters in subjects.

CON ( )IFG ( )IGT ( )T1D ( )T2D ( )
CuUCuCuUCuCuUCuCuUCuCuUCu

Glu−0.1570.214−0.1860.196−0.0040.991−0.0710.8260.0110.970−0.0470.867−0.5300.006*0.2250.2790.1090.2060.0180.838
HbA1c−0.0600.681−0.1090.4510.5690.054−0.0660.8380.1350.6310.1200.671−0.0350.867−0.1090.6030.498<0.001*0.0460.591
RBC0.1250.389−0.2310.1060.2410.450−0.2400.452−0.0540.8490.0920.7460.0590.7810.1360.516−0.0980.2550.0730.395
Hb−0.0070.959−0.1510.2950.3080.330−0.1310.685−0.0110.9700.0850.7630.2280.2730.2560.216−0.0360.6730.0390.650
UCu−0.2040.1540.2370.4590.2840.3050.0960.6490.1840.032*
Zn0.2980.036*−0.1210.4020.1160.7200.0570.8610.1180.676−0.1860.5060.4030.046*0.1400.5060.1580.065−0.0480.581
UZn−0.0170.906−0.0430.7670.1930.5430.6730.017*0.1180.6760.0630.8230.0600.7750.2020.3330.0480.5770.2040.017*
BUN0.0250.866−0.0590.685−0.1790.5790.1890.556−0.2030.4690.1130.690−0.1860.3740.1300.5360.2480.001*0.2480.003*
Cre−0.0900.5330.0400.781−0.4270.166−0.3470.2690.1430.6110.3020.2730.0920.6630.3290.1090.1250.1450.357<0.001*
eGFR0.1080.457−0.0030.9830.3290.2960.3660.2410.0770.785−0.3320.226−0.0250.904−0.0340.873−0.1460.090−0.337<0.001*
CHO0.0440.7620.1520.2920.1930.5480.1790.578−0.3490.202−0.2210.4280.1980.342−0.4900.013*0.1190.1650.0320.708
TG0.0920.5260.1510.2950.1990.5360.5220.082−0.1160.681−0.2700.330−0.0230.9110.2680.1960.0760.379−0.0460.597
HDL−0.1480.307−0.0530.717−0.0460.887−0.1590.6200.5560.0320.0150.958−0.1510.472−0.4760.016*0.1320.124−0.0170.845
LDL−0.0070.963−0.0320.8270.3590.2520.1030.7500.1200.6700.1800.5200.1010.630−0.5400.005*0.1280.1370.1510.079

Data presentation and abbreviations spelt out forms are the same as the description for Table 1. * for the association.